Bilal Arif
Chief Tech/Sci/R&D Officer bij SAREPTA THERAPEUTICS, INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
Bilal Arif is currently the Chief Technical Operations Officer & Executive VP at Sarepta Therapeutics, Inc. Previously, he worked as the Vice President-Technical Operations at Momenta Pharmaceuticals, Inc. from 2017 to 2019.
Mr. Arif completed his undergraduate degree at McGill University, his graduate degree at Tufts University, and his MBA at Instituto de Empresa SL.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 08-03-2024 | 25 222 ( 0.03% ) | 3 M $ | 31-03-2024 |
Actieve functies van Bilal Arif
| Bedrijven | Functie | Begin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31-12-2022 |
Eerdere bekende functies van Bilal Arif
| Bedrijven | Functie | Einde |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02-01-2019 |
Opleiding van Bilal Arif
| McGill University | Undergraduate Degree |
| Tufts University | Graduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
